Inside the drugs factory: How captagon is fuelling the war in Sudan

Deep within an industrial wasteland on the eastern bank of the Nile, three inconspicuous, half-finished buildings stand surrounded by a minefield. For months, residents were warned by Rapid Support Forces (RSF) fighters to avoid this walled compound. Inside, authorities discovered machinery and chemical products allegedly used to produce approximately 1,000 captagon pills per hour. This cheap, addictive amphetamine, popular among fighters and partygoers in the Middle East, has become a significant concern for Arab governments. The RSF reportedly distributes the drug to its fighters to enhance alertness and suppress hunger, while also selling it to civilians for profit. Until recently, Syria was the primary hub for captagon production. However, the fall of Bashar al-Assad’s government disrupted the industry, leading to the shutdown of numerous laboratories and smuggling routes. Despite this, Sudan’s ongoing conflict has provided fresh opportunities for captagon production. Earlier this year, the Sudanese Armed Forces (SAF) forced the RSF out of Khartoum and its surrounding areas, uncovering a captagon factory near the al-Jaili oil refinery in February. The facility contained five machines, two of which were operational at the time of discovery. Authorities also found pills bearing the double crescent symbol, a hallmark of illegal captagon production. The other machines were still in their packaging, suggesting the facility was in its early stages of operation. Shipping labels on the equipment indicated it was imported via a Dubai-based company, Amass Middle East Shipping Services, though the company did not respond to inquiries. The UAE has been accused of supplying arms to the RSF, though it denies these allegations. Experts noted the equipment’s similarity to that found in Syrian laboratories, raising concerns about a potential connection between Sudanese and Syrian criminal networks. The compound also contained hundreds of packets of white powder, labeled as veterinary supplements and electrolytes, though their contents remain under investigation. Sudanese police suspect the powder could be precursor materials for captagon production. The discovery of this factory follows earlier findings of captagon labs in Sudan, indicating a growing trend. Authorities are investigating whether the drug was being manufactured for export, given the lucrative Gulf market just across the Red Sea. The collapse of the Syrian captagon market has left a void, and Sudan appears to be filling it. Experts warn that the technical knowledge to produce captagon remains intact and could be redeployed elsewhere, posing a continued threat to regional security.